UAB

Innocan Pharma Announces 5000 Units Sale and Expansion to Lithuania, Latvia & Estonia Markets

Retrieved on: 
Monday, May 1, 2023
Standby Equity Distribution Agreement, CSE, Skin care, AB, FSE, USD, UAB, Intermediary, Distribution, CBD, Pharmaceutical industry, Beauty

As part of the multi-year Distribution Agreement, UAB Medexy has an exclusive right to distribute both of Innocan's SHIR™ and RELIEF&GO™ brands in Lithuania, Latvia & Estonia, based on an agreed purchase forecast.

Key Points: 
  • As part of the multi-year Distribution Agreement, UAB Medexy has an exclusive right to distribute both of Innocan's SHIR™ and RELIEF&GO™ brands in Lithuania, Latvia & Estonia, based on an agreed purchase forecast.
  • UAB Medexy's first order under the Distribution Agreement is for over 5000 units of SHIR™ and RELIEF&GO™ products.
  • Innocan Pharma and SHIR™/ RELIEF&GO™ will now be stepping-up to become market leaders in many European countries.
  • Iris Bincovich, CEO of InnoCan stated that "We are humbled to have a leading European market leader such as UAB Medexy as our market-partner in Lithuania, Latvia & Estonia.

Protective Life Corporation Announces Board of Directors Updates

Retrieved on: 
Tuesday, April 4, 2023
Professional Services, Insurance, Finance, Dai, Federation of American Hospitals, Encompass Health, United States Merit Systems Protection Board, Hospital, Dai-ichi Life, Multimedia, UAB, Federation, Knowledge, Protective Stadium, Dai-ichi, Management

Protective Life Corporation (Protective), a subsidiary of Dai-ichi Life Holdings, Inc. (Dai-ichi, TSE:8750), announces updates to its board of directors.

Key Points: 
  • Protective Life Corporation (Protective), a subsidiary of Dai-ichi Life Holdings, Inc. (Dai-ichi, TSE:8750), announces updates to its board of directors.
  • View the full release here: https://www.businesswire.com/news/home/20230404006045/en/
    “We are pleased to welcome three new, well-respected leaders to Protective’s Board of Directors,” said Michael J. Morrissey, Chairman of Protective’s Board of Directors.
  • Their combined knowledge and experience of the financial and medical industries will bring a depth of leadership to the Protective Board of Directors.
  • Mr. Yamaguchi will replace Toshiaki Sumino, Director, Managing Executive Officer of Dai-ichi Life Holdings, Inc. and Managing Executive Officer of The Dai-ichi Life Insurance Co., Ltd., who has now completed his board term for Protective.

Prapela receives NIH Grant to improve the treatment of Apnea of Prematurity in collaboration with Tufts Medical Center and the University of Alabama at Birmingham

Retrieved on: 
Thursday, April 6, 2023
National Institute on Drug Abuse, Medical school, Birmingham School of Law, University, Caffeine, Marketing, NICU, ISO, Parent, Apnea, Neonatology, Sleep, ME, Electronics, Bangladesh Technical Education Board, Associate, Trial of the century, UAB, Infant, Nicu's Spoon Theater Company, Blueprint, Tufts Medical Center, MD, Premature, Child, AOP, NIDA, Birmingham, System, FDA, Safety, NIH, Caregiver, Dietary supplement, Birth control, Pharmaceutical industry, Medical device, Medicine

NIH Blueprint MedTech grant supports the development of a medical device that can improve the treatment of apnea in preterm newborns.

Key Points: 
  • NIH Blueprint MedTech grant supports the development of a medical device that can improve the treatment of apnea in preterm newborns.
  • Recently, the FDA awarded Prapela's pad with Breakthrough Device Designation as a promising treatment option for apnea of prematurity.
  • So, we are excited to be working with Prapela and UAB on a very promising therapy for apnea in preterm newborns."
  • "The clinical study will help us determine if we can further reduce apnea episodes and the amount of caffeine used to treat apnea of prematurity."

Bruno Event Team Announces Rebrand to Eventive Sports

Retrieved on: 
Tuesday, March 14, 2023
The Tradition, Magic City Classic, NYSE, Alston & Bird, English Football League, ALA, Billie Jean King Cup, United States Football League (2022), Alabama State University, NCAA, University, General counsel, Olympic Soccer, Counsel, History, Sport, Southeastern Conference baseball tournament, UAB, Corporation

Birmingham, ALA, March 14, 2023 (GLOBE NEWSWIRE) -- Birmingham, ALA – Bruno Event Team, a leading sports event management company, announced today that it is rebranding to Eventive Sports to better align its brand with the company’s vision and mission.

Key Points: 
  • Birmingham, ALA, March 14, 2023 (GLOBE NEWSWIRE) -- Birmingham, ALA – Bruno Event Team, a leading sports event management company, announced today that it is rebranding to Eventive Sports to better align its brand with the company’s vision and mission.
  • Since 1996, Eventive Sports has set itself apart in sports event management.
  • Eventive Sports also supports gameday operations for the United States Football League, The University of Alabama, Auburn University, UAB, and Alabama State University.
  • “I am excited to be a part of the team at Eventive Sports.

University of Alabama at Birmingham Reaches 1,000 Patient Pulmonary Exams With Dynamic Digital Radiography

Retrieved on: 
Tuesday, March 7, 2023
Doctor of Philosophy, FCCP, Diaphragm, Radiological Society of North America, RSNA, Acquisition, Clinical research, RIS, COPD, Medicine, Hospital, COVID, Shimadzu, UAB Hospital, University, PACS, Annual general meeting, Roflumilast, McGough, Imaging, DDR, Assistant professor, Motion, University of Texas Health Science Center Department of Radiology, Patient, Lung, MD, Perfusion, Fluoroscopy, UAB, Workflow, Senior, Lung cancer, Kirklin Clinic, Medical imaging, Radiology

UAB Medicine is a leading lung transplant center and one of busiest in the US, with one-year patient and graft survival rates higher than national averages.

Key Points: 
  • UAB Medicine is a leading lung transplant center and one of busiest in the US, with one-year patient and graft survival rates higher than national averages.
  • DDR is a radiographic technique that provides a series of individual digital X-ray images acquired at high speed and low radiation dose.
  • These images provide diagnostic-quality views of anatomical structures in motion and the ability to visualize the dynamic interaction with physiological changes over time.
  • DDR enables efficient routine dynamic imaging, for example sniff tests of their transplant patients, without dedicated scheduling or disrupting the regular reading schedule.

Hollywood Presbyterian Medical Center & Sentara Healthcare implement clinical quality improvement solution from Wolters Kluwer

Retrieved on: 
Thursday, March 9, 2023
Technology, Managed Care, Hospitals, Science, Nursing, Clinical Trials, Health, Other Science, Other Education, Research, Continuing, Training, Software, Networks, Education, Practice Management, Artificial Intelligence, Magnet, Wolters Kluwer, New York State Education Department, Learning, MSLS, Student, Pressure, Governance, Institute of Museum and Library Services, Patient, Multimedia, Artificial intelligence, Hospital, University, Caregiver, UAB, Organization, Birmingham School of Law, HPMC, Senior, Sentara Healthcare

Hollywood Presbyterian Medical Center (HPMC) and Norfolk, VA-based Sentara Healthcare are implementing Wolters Kluwer Health’s Ovid® Synthesis Clinical Evidence Manager solution, to support evidence-based clinical research initiatives.

Key Points: 
  • Hollywood Presbyterian Medical Center (HPMC) and Norfolk, VA-based Sentara Healthcare are implementing Wolters Kluwer Health’s Ovid® Synthesis Clinical Evidence Manager solution, to support evidence-based clinical research initiatives.
  • “Sentara has used Ovid for years to help our clinicians with research,” said Suzanne Duncan, MSLS, Director of Library Services for Sentara Healthcare.
  • “We have now added Ovid Synthesis Clinical Evidence Manager to assist with all our clinical research and tracking, as well as compliance for Magnet recognition and renewal.
  • The division of Wolters Kluwer supports clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions.

The Multiple Sclerosis Association of America (MSAA) Focuses on MS at All Stages of Life During MS Awareness Month

Retrieved on: 
Wednesday, March 1, 2023
Knowledge, Learning, Blog, School, University, Family, Keck School of Medicine of USC, Disease, Life, Ageing, Journey, Patient, Child, Multiple sclerosis, Hope, Classic Arts Showcase, Pediatrics, UAB, Month, Risk, FA WSL Spring Series, MSAA, Parent, MS, USC, Education, Birth control, Nursing, Video game, Online shopping

We are dedicated to spreading awareness, education, and support to individuals, families, and care partners in the MS community, and this month is no different.

Key Points: 
  • We are dedicated to spreading awareness, education, and support to individuals, families, and care partners in the MS community, and this month is no different.
  • Listen in as they explore how MS affects children and teens in addition to what parents should know and consider when talking to their healthcare providers.
  • To access information and resources provided by MSAA during MS Awareness Month, or to register for our events, please visit the MS Awareness Month hub page at https://mymsaa.org/awarenessmonth/ .
  • To learn more about MS Awareness Month and MSAA's scheduled digital activities, please contact Diana Cruz, Manager of Public Relations & Engagement at (800) 532-7667, ext.

Endomimetics™ Announces a Research Collaboration Agreement with BISCO, Inc., to Support Development of a Dental Application of Bionanomatrix™

Retrieved on: 
Tuesday, February 14, 2023
Alabama Department of Public Health, Pulp necrosis, Texas Department of Housing and Community Affairs, BISCO, Pediatric dentistry, University, UAB, Research, PH, AIA, University of Alabama, Dental care, Associate, DPC, Tooth discoloration, Radioactive decay, Dentistry

BISCO is a company dedicated to improving the ability to bond dental restorations.

Key Points: 
  • BISCO is a company dedicated to improving the ability to bond dental restorations.
  • The total funding of $700,000 will be used to develop a novel bioactive Direct Pulp Capping (DPC) material using Endomimetics Bionanomatrix™ to better treat dental caries and other dental ailments.
  • Conventional DPC materials have shown high solubility, low sealing capacity, weak physical properties, uncontrolled pulp necrosis, and unpredictable clinical success.
  • The development of the bioactive DPC began in early 2023 and is expected to run for two years.

Arkansas PVC Pipe Helps Provide Access to Clean Water for Rural Alabamans

Retrieved on: 
Wednesday, February 8, 2023
Well, The Vinyl Institute, Museum of Black Arkansans and Performing Arts Center, University, Drinking water, Water, The Water, Corrosion, Jet stream, USDA, Investment, PVC, WWT, Farm, Poverty, Drinking, Black Belt, Water supply, Cooking, UAB, Senate, Partnership, AR, Plumbing, Renewable energy

The PVC pipe will be used in 50 new water wells across a five-county area in Alabama including Dallas, Perry, Wilcox, Marengo, and Sumter counties.

Key Points: 
  • The PVC pipe will be used in 50 new water wells across a five-county area in Alabama including Dallas, Perry, Wilcox, Marengo, and Sumter counties.
  • PVC pipe is used in the water well casing due to its resistance to corrosion and its cost-effectiveness.
  • Water wells are a cost-effective solution to delivering this resource to homes in small, rural communities," said Senator John Boozman.
  • The Water Well Trust (WWT), a national nonprofit helping rural Americans get access to a clean, safe water supply, is working with H2 Alabama to help fund the construction of the wells.

SELLAS Life Sciences to Host Key Opinion Leader Webinar on Galinpepimut-S Acute Myeloid Leukemia Program

Retrieved on: 
Thursday, January 19, 2023
Oncology, UAB, EST, University, Therapy, AML, Experiment, Neoplasm, Acute myeloid leukemia, Division, MD, American Society for Pharmacology and Experimental Therapeutics, Haematopoietic system, Cancer, WT1, Chronic myelogenous leukemia, Assistant, Patient, Hematology, SLS, GPS, Pharmaceutical industry, Medicine

NEW YORK, Jan. 19, 2023 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, will host a virtual key opinion leader event to discuss the current treatment landscape for patients suffering from acute myeloid leukemia (AML) and the potential for galinpepimut-S (GPS) as a treatment solution.

Key Points: 
  • The webinar event will feature Omer Jamy, MD who is principal investigator of the Phase 3 REGAL study at the University of Alabama at Birmingham (UAB), one of the highest enrolling REGAL sites.
  • He is currently Assistant Professor of Medicine at UAB in the Division of Hematology and Oncology and Associate Scientist, Experimental Therapeutics at the O'Neal Comprehensive Cancer Center.
  • Dr. Jamy is principal investigator on several clinical trials in addition to REGAL, focusing on AML, chronic myelogenous leukemia, and allogeneic stem cell transplantation.
  • A live question and answer session will follow the formal presentation and replay will be available here following the event.